Vermont Pricing Disclosures

Under Vermont law, pharmaceutical marketers are required to disclose the prices of the drugs they market to Vermont doctors and other persons authorized to prescribe drugs in Vermont. When disclosing the prices of the drugs they market, the pharmaceutical marketers must also disclose the prices of others drugs in the same therapeutic class.

Below, you will find links to the disclosure forms for each of the pharmaceutical products that Boehringer Ingelheim Pharmaceuticals Inc. markets and for which such disclosure is required. The disclosures are provided in the format required by the Vermont law and subsequent guidance documents.

The Average Wholesale Price ("AWP") listed for Boehringer Ingelheim Pharmaceuticals, Inc. (“BIPI”) Marketed Products is derived by the third party publisher. BIPI does not set or provide an AWP price to or for any third party publisher, nor does BIPI assign an AWP to any of its products.

Prescription Medicines:

California State Requirements

To read our annual public declaration of compliance with our Corporate Compliance Program,
click here.

California has implemented a law requiring that companies establish a specific annual dollar limit on gifts, promotional materials, or items or activities that they may provide to healthcare professionals. We have set an annual dollar limit of two thousand five hundred dollars per healthcare professional. Please note that this amount represents the maximum limit, and does not represent the actual average annual amount per healthcare professional. Drug samples given to healthcare professionals intended for free distribution to patients and financial support for continuing education and health education scholarships are exempt from this limit, as are payments to healthcare professionals for legitimate professional services.